Early Low-grade Gastric MALToma Rarely Transforms Into Diffuse Large Cell Lymphoma or Progresses Beyond the Stomach and Regional Lymph Nodes
Journal
Journal of the Formosan Medical Association
Journal Volume
109
Journal Issue
6
Pages
463-471
Date Issued
2010
Author(s)
Abstract
Background/Purpose: Gastric mucosa-associated lymphoid tissue lymphoma (MALToma) usually presents at an early stage involving only the stomach and/or regional lymph nodes. Although a sequential transformation from low-grade gastric MALToma (GM) to high-grade GM to secondary diffuse large B-cell lymphoma (DLBCL) is commonly assumed, documented cases of transformation are rare. We aim to determine the frequency of transformation. Methods: We identified 55 early low-grade GMs, 18 early high-grade GMs, and 13 advanced GMs at the National Taiwan University Hospital from 1995 to 2005. The median follow-up time was 59 months. Results: We found that only one early low-grade GM and two early high-grade GMs transformed into secondary DLBCLs and progressed outside the stomach and regional lymph nodes. Significantly, we identified 13 low-grade GMs that were refractory to Helicobacter eradication therapy or relapsed after initial response. All 13 cases had been followed-up for at least 3 years without development of secondary DLBCLs. The frequency of transformation for early low-grade GM was less than 2% (1/55). Although two lymphoma-unrelated mortalities were identified, none of the 55 patients with early-low grade GMs died of the disease. Conclusion: Compared with chronic lymphocytic leukemia, which has a 16% transformation rate and a median transformation time of 24 months, we conclude that early low-grade GM rarely transforms into secondary DLBCL or progresses beyond the stomach. Without transformation or progression, patients with early low-grade GM rarely die of the disease and should be treated conservatively. ? 2010 Formosan Medical Association & Elsevier.
SDGs
Other Subjects
adult; aged; article; B cell lymphoma; cancer growth; chronic lymphatic leukemia; eradication therapy; female; follow up; Helicobacter; human; large cell lymphoma; lymph node metastasis; major clinical study; male; malignant transformation; mucosa associated lymphoid tissue lymphoma; treatment response; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cell Transformation, Neoplastic; Disease Progression; Female; Follow-Up Studies; Gastric Mucosa; Hospitals, University; Humans; Kaplan-Meiers Estimate; Lymph Nodes; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Taiwan; Treatment Outcome
Type
journal article